Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

CD81 and CD9 work independently as extracellular components upon fusion of sperm and oocyte

View through CrossRef
Summary When a sperm and oocyte unite into one cell upon fertilization, membranous fusion between the sperm and oocyte occurs. In mice, Izumo1 and a tetraspanin molecule CD9 are required for sperm-oocyte fusion as one of the oocyte factors, and another tetraspanin molecule CD81 is also thought to involve in this process. Since these two tetraspanins often form a complex upon cell-cell interaction, it is probable that such a complex is also formed in sperm-oocyte interaction; however, this possibility is still under debate among researchers. Here we assessed this problem using mouse oocytes. Immunocytochemical analysis demonstrated that both CD9 and CD81 were widely distributed outside the oocyte cell membrane, but these molecules were separate, forming bilayers, confirmed by immunobiochemical analysis. Electron-microscopic analysis revealed the presence of CD9- or CD81-incorporated extracellular structures in those bilayers. Finally, microinjection of in vitro-synthesized RNA showed that CD9 reversed a fusion defect in CD81-deficient oocytes in addition to CD9-deficient oocytes, but CD81 failed in both oocytes. These results suggest that both CD9 and CD81 independently work upon sperm-oocyte fusion as extracellular components.
Title: CD81 and CD9 work independently as extracellular components upon fusion of sperm and oocyte
Description:
Summary When a sperm and oocyte unite into one cell upon fertilization, membranous fusion between the sperm and oocyte occurs.
In mice, Izumo1 and a tetraspanin molecule CD9 are required for sperm-oocyte fusion as one of the oocyte factors, and another tetraspanin molecule CD81 is also thought to involve in this process.
Since these two tetraspanins often form a complex upon cell-cell interaction, it is probable that such a complex is also formed in sperm-oocyte interaction; however, this possibility is still under debate among researchers.
Here we assessed this problem using mouse oocytes.
Immunocytochemical analysis demonstrated that both CD9 and CD81 were widely distributed outside the oocyte cell membrane, but these molecules were separate, forming bilayers, confirmed by immunobiochemical analysis.
Electron-microscopic analysis revealed the presence of CD9- or CD81-incorporated extracellular structures in those bilayers.
Finally, microinjection of in vitro-synthesized RNA showed that CD9 reversed a fusion defect in CD81-deficient oocytes in addition to CD9-deficient oocytes, but CD81 failed in both oocytes.
These results suggest that both CD9 and CD81 independently work upon sperm-oocyte fusion as extracellular components.

Related Results

Cholesterol sensing by CD81 is important for hepatitis C virus entry
Cholesterol sensing by CD81 is important for hepatitis C virus entry
CD81 plays a central role in a variety of physiological and pathological processes. Recent structural analysis of CD81 indicates that it contains an intramembrane cholesterol-bindi...
GPC3‐CD81 axis in the HCV mediated liver carcinogenesis
GPC3‐CD81 axis in the HCV mediated liver carcinogenesis
Glypican‐3 (GPC3) is highly over‐expressed in human hepatocellular carcinomas (HCC). GPC3 decreases liver regeneration by interacting with CD81. Other groups have shown that activa...
CD81: a novel lymphoma therapeutic target
CD81: a novel lymphoma therapeutic target
Abstract Tetraspanin CD81 was initially described as a target of a monoclonal antibody (mAb) able to inhibit proliferation of lymphomas and activated lymphocytes, wh...
O-059 ntermetabolites of cholesterol synthesis in granulosa cell and oocyte aging
O-059 ntermetabolites of cholesterol synthesis in granulosa cell and oocyte aging
Abstract With the development of society, there has been a significant delay in female fertility and an increasing desire for c...
Modulation of CD81 By Epigenetic Drug Combination Sensitizes Acute Lymphoblastic Leukemia Via Decreased BTK Signaling
Modulation of CD81 By Epigenetic Drug Combination Sensitizes Acute Lymphoblastic Leukemia Via Decreased BTK Signaling
Background We previously discovered that the epigenetic drug combination - azacitidine (aza, DNMTi) and panobinostat (pano, HDACi) can sensitize ALL cells to chemoth...

Back to Top